SARS-CoV-2 Alpha variant

Variant of SARS-CoV-2, the virus that causes COVID-19

SARS-CoV-2 Alpha variant    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

SARS-CoV-2 Alpha variant: Variant of SARS-CoV-2, the virus that causes COVID-19
Alpha variant, also known as lineage B.1.1.7, is a variant of SARS-CoV-2, the virus that causes COVID-19. One of several variants believed to be of particular importance, it is estimated to be 40%–80% more transmissible than the wild-type SARS-CoV-2 and was detected in November 2020 from a sample taken in September, during the COVID-19 pandemic in the United Kingdom; it began to spread quickly by mid-December, and is correlated with a significant increase in SARS-CoV-2 infections in the country. This increase is thought to be at least partly because of one or more mutations in the virus's spike protein. The variant is also notable for having more mutations than normally seen.


Novavax vaccine over 90% effective in U.S. trial [Video]

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer..

Credit: Reuters - Politics     Duration: 01:41Published

You Might Like

US CDC classifies Delta variant as 'variant of concern'

The US Centers for Disease Control and Prevention has classified the Delta, a highly transmissible Covid-19 variant first identified in India, as a "variant of concern." "The B.1.1.7 (Alpha), B.1.351..
IndiaTimes - Published

More infectious Delta variant behind 2nd wave, says study

The Delta variant or B.1.617.2 strain, which was first detected in India, is more infectious than the Alpha variant or B.1.1.7, first detected in the United Kingdom. β€œOur data indicates B.1.617.2..
IndiaTimes - Published

Delta variant primary cause behind India's second Covid wave: Expert panel

A study by ​​The Indian SARS-CoV-2 Consortium on Genomics (INSACOG) said the Delta variant, first found in India, is the "primary cause" behind the second Covid-19 wave. "​B.1.617 variant & its..
IndiaTimes - Published

Covaxin effectively neutralises all key emerging variants, says study published in Oxford journal

Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first identified in India and the UK, its developer..
IndiaTimes - Published

India, UK variants equally transmissible, finds study

Public Health England, the executive agency of the UK department of health, has equated the novel coronavirus sub-lineage, B.1.617.2 of Indian variant or double mutant B.1.617, with the UK strain..
IndiaTimes - Published

Search this site and the web: